Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB

S.L

S.L patent portfolio — 179 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
Status
Public
HQ
SAN DIEGO, CA, EU
Programs
15
Drugs
11
Patents
179
All projects Drug pipeline Patents News & analysis
Intelligence · Patents

S.L patents

179 pharmaceutical patents indexed for S.L. 16 expire within 24 months.

S.L has 179 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 16 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

179 patents

Patent portfolio

Page 1 of 4

  1. US 12311017

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12251378

    Long-acting local anesthetic formulation

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12202822

    Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12156879

    Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12060555

    MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12029787

    Method for generating recombinant poxviruses

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12018255

    Compositions and methods for treating disorders of genomic imprinting

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11952419

    Reagents and methods for treating cancer and autoimmune disease

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11866491

    Antibody for binding to interleukin 4 receptor

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11866488

    Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11833254

    Discoidal nano universal platform for efficient delivery of PNAs

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11786479

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11512078

    Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11497197

    Methods for enhancing poultry growth and performance

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11479617

    Chelator-functionalized glycosaminoglycans

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11459381

    Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11390613

    Azole analogues and methods of use thereof

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11364309

    Neuronal enhancers

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11338026

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11173173

    Methods for treating chemoresistant cancer-initiating cells

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11103523

    Self-assembled brush block copolymer-nanoparticles for drug delivery

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11078264

    Inhibiting granulocyte macrophage-colony stimulating factor (GM-CSF) prevents preterm birth

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11020459

    Factor VIII formulations

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11008378

    Compositions and methods for immunomodulation in an organism

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10870625

    Zwitterionic propargyl-linked antifolates useful for treating bacterial infections

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10842826

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10814006

    Fluorescent prodrugs

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10780058

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10774141

    Antibody for binding to interleukin 4 receptor

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10632072

    Systems and methods for continuous manufacturing of liposomal drug formulations

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10537594

    Targeted transplantation of mitochondria to hepatocytes

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10501801

    Identification of tumor-protective epitopes for the treatment of cancers

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10464993

    Compositions and methods for immunomodulation in an organism

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10457726

    Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10344040

    Pyridone and aza-pyridone compounds and methods of use

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10280158

    Immune adjustment compound, use thereof and pharmaceutical composition comprising same

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10266539

    Polymorph of Syk inhibitors

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10226488

    Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10092583

    Imidazopyridines Syk inhibitors

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10093684

    Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10053469

    Pyridone and aza-pyridone compounds and methods of use

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9975983

    Bio-reducible self-assembled liquid crystalline block copolymer for drug delivery

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9969790

    Compositions and methods for immunomodulation in an organism

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9949932

    Formulation of syk inhibitors

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9932387

    Compositions and methods for immunomodulation in an organism

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9918939

    Formulation of Syk inhibitors

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9839636

    Itraconazole analogues and methods of use thereof

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9796718

    6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does S.L have?

179 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do S.L patents expire?

16 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.